Entera Bio Ltd. Maintains Nasdaq Listing with Price Compliance
Company Announcements

Entera Bio Ltd. Maintains Nasdaq Listing with Price Compliance

Entera Bio Ltd (ENTX) just unveiled an announcement.

Entera Bio Ltd., an Israeli biotech firm, has successfully met Nasdaq’s minimum bid price requirement, ensuring its continued listing on the stock exchange. The company made this achievement public through a press release, underlining its commitment to maintain the standards set by financial regulators, a move that may inspire investor confidence in its fiscal health and governance.

See more data about ENTX stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskEntera Bio Highlights Q3 2024 Financials and FDA Anticipation
TheFlyEntera Bio, Opko Health provide update on PK/PD results of GLP-1/Glucagon
TipRanks Auto-Generated NewsdeskEntera Bio Clarifies Non-Binding Information Disclosure
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App